Author

Fabio Salvatore Macaluso

REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY
REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY

Fabio Salvatore Macaluso  et al.

VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE
VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE

SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE

Fabio Salvatore Macaluso  et al.

REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY
REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY

SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Fabio Salvatore Macaluso  et al.

SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

Fabio Salvatore Macaluso  et al.

EFFECTIVENESS AND SAFETY OF ON-DEMAND FERRIC CARBOXYMALTOSE INFUSION STRATEGY FOR IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE PATIENTS
EFFECTIVENESS AND SAFETY OF ON-DEMAND FERRIC CARBOXYMALTOSE INFUSION STRATEGY FOR IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE PATIENTS

Fabio Salvatore Macaluso  et al.

SARCOPENIA IS A POOR PROGNOSTIC FACTOR FOR ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN’S DISEASE
SARCOPENIA IS A POOR PROGNOSTIC FACTOR FOR ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN’S DISEASE

Fabio Salvatore Macaluso  et al.

BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS ON BIOLOGICS: A PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES

Fabio Salvatore Macaluso  et al.

Item 1 - 10 / 10
1